• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: Is there a role for antibiotic diversity?

Giuseppe

Emeritus
[Source: Antimicrobial Agents and Chemotherapy, full text: (LINK). Abstract, edited.]

Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: Is there a role for antibiotic diversity?


C. Pl?ss-Suard a, A. Pannatier b, A. Kronenberg c, K. M?hlemann c and G. Zanetti d

Author Affiliations: <SUP>a</SUP>Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland and School of Pharmaceutical Science, University of Geneva and University of Lausanne, Geneva, Switzerland <SUP>b</SUP>Service of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland and School of Pharmaceutical Science, University of Geneva and University of Lausanne, Geneva, Switzerland <SUP>c</SUP>Institute for Infectious Diseases, University Hospital, Bern, Switzerland <SUP>d</SUP>Service of Hospital Preventive Medicine and Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland



ABSTRACT

The present study aims at evaluating the relationship between the rates of resistance of Pseudomonas aeruginosa towards carbapenems and the level as well as the diversity of antibiotic consumption. Data were retrospectively collected from 20 acute care hospitals distributed across 3 regions of Switzerland over the period 2006 ? 2010. The main outcome of the present study was the rate of resistance to carbapenems among P. aeruginosa. Putative predictors included the total antibiotic consumption and carbapenem consumption in defined daily doses per 100 bed-days, the proportion of very broad-spectrum antibiotics, and the Peterson index. The present study confirmed a correlation between carbapenem use and carbapenem resistance rates at the hospital and regional levels. The impact of diversifying the range of antibiotics used against P. aeruginosa resistance was suggested by: (i) a positive correlation in multivariate analysis between the above mentioned resistance and the proportion of consumed antibiotics having a very broad spectrum of activity (coefficient = 1.77; 95% CI 0.58 ? 2.96; p < 0.01) and (ii) a negative correlation between resistance and diversity of antibiotic use as measured by the Peterson homogeneity index (coefficient = −0.52; p < 0.05). It was concluded that promoting heterogeneity plus parsimony in the use of antibiotics appears as a valuable strategy to minimize the spread of carbapenem resistance in P. aeruginosa in hospitals.



FOOTNOTES

Corresponding author: Catherine Pl?ss-Suard, Centre Hospitalier Universitaire Vaudois, M?decine Pr?ventive Hospitali?re, Av du Bugnon 46, 1011 Lausanne, Switzerland, Phone: ++41 79 204 77 84, Fax: ++41 21 314 02 62, Email: Catherine.Pluss@chuv.ch

Copyright ? 2013, American Society for Microbiology. All Rights Reserved.
-
------
 
Back
Top Bottom